Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder

@article{Huang2011LongTermOW,
  title={Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder},
  author={Y. Huang and Ming-Horng Tsai},
  journal={CNS Drugs},
  year={2011},
  volume={25},
  pages={539-554}
}
  • Y. Huang, Ming-Horng Tsai
  • Published 2011
  • Psychology, Medicine
  • CNS Drugs
    • Attention-deficit hyperactivity disorder (ADHD), a common neuro-behavioural disorder characterized by inattention, hyperactivity and impulsivity, is a chronic disorder and often persists into adulthood. CNS stimulants have been the most well known treatment for ADHD for several decades due to their high effectiveness, good safety profiles and relatively minor adverse effects. Non-stimulant agents, including atomoxetine, extended-release guanfacine and extended-release clonidine (US FDA approved… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    28 Citations
    Background Citations
    6
    Results Citations
    1
    28 Citations
    Citation Type

    Citation Type

    Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
    • 19
    The Potential Role of Neuroendocrine in Patients with Attention-Deficit/Hyperactivity Disorder
    • 5
    • PDF
    Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
    • 13
    ReviewAttention deficit hyperactivity disorderTrastorno por déficit de atención con hiperactividad
    Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
    Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    • 8
    Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review
    • 54
    • PDF
    Attention-deficit hyperactivity disorder and cardiac vagal control: a systematic review
    • 57
    Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
    • 10
    Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers.
    • 17

    References

    SHOWING 1-10 OF 130 REFERENCES
    Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms
    • 21
    Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
    • 188
    Attention-deficit hyperactivity disorder
    • 1,240
    • PDF
    Stimulant Medication Withdrawal During Long-term Therapy in Children With Comorbid Attention-Deficit Hyperactivity Disorder and Chronic Multiple Tic Disorder
    • 45
    Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder.
    • 130
    Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
    • S. Wigal
    • Psychology, Medicine
    • CNS Drugs
    • 2009
    • 146
    Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.
    • 53
    First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
    • 47
    Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse?
    • 757
    • PDF
    Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    • 187
    • PDF